Heart Disease Channel
Related Channels

Dabigatran FDA Approval

If you have a certain type of irregular heart rhythm called atrial fibrillation, your healthcare provider may prescribe dabigatran etexilate mesylate (Pradaxa®). This mediation is a type of "blood thinner" that works by preventing strokes and blood clots.
Dabigatran received approval from the United States Food and Drug Administration (FDA) in October 2010. It is used as an alternative medication to warfarin (Coumadin®, Jantoven®). Clinical studies have shown that when compared to warfarin, dabigatran is easier to dose, requires less monitoring, and is more effective.
In April 2014, the drug was also approved to treat blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism) and to prevent them from recurring. 
(For more information about this FDA-approved medication, click Dabigatran. This article also looks at how dabigatran works, discusses the results of clinical studies that were done on the effectiveness of the drug, and lists possible side effects.)
Life After a Stent: 5 Realistic Ways to Take Charge of Your Health
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.